Published

Epigenome-wide association study of psilocybin-induced methylome changes in alcohol use disorder

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Translational Psychiatry
Date: 2026-05-26
Source: Crossref
DOI: 10.1038/s41398-026-03961-3
PubMed: 42192100

Authors

Urban Marvin M.Zillich Lea Rieser Nathalie M.Herdener Marcus Spanagel Rainer Vollenweider Franz X.Preller Katrin H.Meinhardt Marcus W.

Watch author

Derived topics and classifications

psilocybin Depression Addiction Neuroplasticity Mechanism of Action Epigenetics Observational Study Genomics Immune Function Observational Study

Citation graph

40 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

10.1093/abm/kax053 10.1371/journal.pone.0263350 10.1038/aps.2014.50 10.1001/jamapsychiatry.2022.2096 10.1177/0269881114565144 10.1080/03007995.2023.2296968 10.1038/s41386-022-01389-z 10.1055/a-1341-1907 10.3389/fpsyt.2024.1386321 10.1007/7854_2021_284 10.3389/fnins.2023.1156319 10.1007/s00702-024-02757-3

Indexed papers citing this DOI

Epigenome-wide association study of psilocybin-induced methylome changes in alcohol use disorder2026-05-26

Related papers

An Examination of Psilocybin Effects on Biomarkers of Longevity, Healthy Aging, and Purpose in LifeClinicalTrials.gov · 2026-08-17 A Randomized, Double-Blind, Single Ascending Dose Study to Identify a Safe and Non-Psychedelic Dose of PsilocybinClinicalTrials.gov · 2026-07-17 The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young AdultsClinicalTrials.gov · 2026-08-14 Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's DiseaseClinicalTrials.gov · 2026-08-07 Single Dose Psilocybin for a Post-surgical Trauma Inpatient Population for Pain, Mood, and Opioid Use DisorderClinicalTrials.gov · 2026-08-06 Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)ClinicalTrials.gov · 2026-07-30 Effect of Psilocybin and Structured Integrated Reframing Therapy on Gut-Brain Axis Biomarkers and Depression in Trauma-Related Major Depressive Disorder: Randomized Controlled TrialClinicalTrials.gov · 2026-07-14 Psilocybin: Capturing Brain Mechanisms of Motivation and Neurocognition in Individuals With Opioid Use DisorderClinicalTrials.gov · 2026-07-09